| 标题 |
Overall survival for amivantamab plus lazertinib versus osimertinib as first-line treatment in Asian participants with EGFR-mutant advanced NSCLC: A MARIPOSA subset analysis |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lung Cancer 作者:Hidetoshi Hayashi; Byoung Chul Cho; Yu Jung Kim; Se-Hoon Lee; Pongwut Danchaivijitr; et al 出版日期:2026-02-04 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)